Danielle D. DeCourcey

Dr. Danielle D. DeCourcey

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Critical Care Medicine
Verified
Journal Article
Closed access
DDDanielle D. DeCourcey
Danielle D. DeCourcey
MSMelanie Silverman
Melanie Silverman
AOAdeolu Oladunjoye
Adeolu Oladunjoye
JWJoanne Wolfe
Joanne Wolfe
Objectives: For children, adolescents, and young adults with complex chronic conditions advance care planning may be a vital component of optimal care. Advance care planning outcomes research has previously focused on seriously ill adults and adolescents with cancer where it is correlated with high-quality end-of-life care. The impact of advance care planning on end-of-life outcomes for children, adolescents, and young adults with complex chronic conditions is unknown, thus we sought to evaluate parental preferences for advance care planning and to determine whether advance care planning and assessment of specific family considerations during advance care planning were associated with differences in parent-reported end-of-life outcomes. Design: Cross-sectional survey. Setting: Large, tertiary care children’s hospital. Subjects: Bereaved parents of children, adolescents, and young adults with complex chronic conditions who died between 2006 and 2015. Interventions: None. Measurement and Main Results: One-hundred fourteen parents were enrolled (54% response rate) and all parents reported that advance care planning was important, with a majority (70%) endorsing that discussions should occur early in the illness course. Parents who reported advance care planning (65%) were more likely to be prepared for their child’s last days of life (adjusted odds ratio, 3.78; 95% CI, 1.33–10.77), to have the ability to plan their child’s location of death (adjusted odds ratio, 2.93; 95% CI, 1.06–8.07), and to rate their child’s quality of life during end-of-life as good to excellent (adjusted odds ratio, 3.59; 95% CI, 1.23–10.37). Notably, advance care planning which included specific assessment of family goals was associated with a decrease in reported child suffering at end-of-life (adjusted odds ratio, 0.23; 95% CI, 0.06–0.86) and parental decisional regret (adjusted odds ratio, 0.42; 95% CI, 0.02–0.87). Conclusions: Parents of children, adolescents, and young adults with complex chronic conditions highly value advance care planning, early in the illness course. Importantly, advance care planning is associated with improved parent-reported end-of-life outcomes for this population including superior quality of life. Further studies should evaluate strategies to ensure high-quality advance care planning including specific assessment of family goals.

1 February 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
DDDanielle D. DeCourcey
Danielle D. DeCourcey
MSMelanie Silverman
Melanie Silverman
AOAdeolu Oladunjoye
Adeolu Oladunjoye
EBEmily M. Balkin
Emily M. Balkin
JWJoanne Wolfe
Joanne Wolfe

1 September 2013 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
DDDanielle D. DeCourcey
Danielle D. DeCourcey
GSGarry M. Steil
Garry M. Steil
DWDavid Wypij
David Wypij
MAMichael S. D. Agus
Michael S. D. Agus
Objectives: Cerebral edema in diabetic ketoacidosis is a devastating complication with significant morbidity and mortality. This entity has traditionally been treated with mannitol, but use of 3% hypertonic saline has become an accepted alternative. We sought to assess if changes in the use of hyperosmolar therapies for treatment of cerebral edema in diabetic ketoacidosis may have influenced mortality over the last decade. Design: Retrospective cohort study. Setting: Patients discharged between 1999 and 2009 from 41 children’s hospitals that provided data to the Pediatric Health Information System database. Patients: A total of 43,107 children (age < 19) with diagnosis codes related to diabetic ketoacidosis were identified and further classified as having cerebral edema if treated with mannitol and/or 3% hypertonic saline. Interventions: None. Measurements and Main Results: Billing for 3% hypertonic saline and mannitol was quantified, and mortality associated with both diabetic ketoacidosis and cerebral edema in diabetic ketoacidosis was examined. Overall mortality in diabetic ketoacidosis was 0.25% and significantly decreased (p < 0.001) over the study period, whereas the frequency of treatment with hyperosmolar agents (3.8%) was unchanged. Use of mannitol as a sole agent decreased from 98% to 49%, 3% hypertonic saline as a sole agent increased from 2% to 39%, and combined therapy increased from 0% to 10%. Use of 3% hypertonic saline alone was associated with a higher mortality than mannitol alone (adjusted odds ratio, 2.71 [95% CI, 1.01–7.26]) in patients treated for cerebral edema. Similar results were obtained after adjustment for the propensity to receive hypertonic saline (adjusted odds ratio, 2.33 [95% CI, 1.07–5.07]) and in the subset of subjects receiving mechanical ventilation (adjusted odds ratio, 3.27 [95% CI, 1.12–9.60]). Conclusion: Hypertonic saline has replaced mannitol as the most commonly used agent at many institutions for treatment of cerebral edema in diabetic ketoacidosis. In our analysis, however, use of hypertonic saline as a sole agent was associated with an increased risk of mortality. Recognizing the limitations of administrative data, we conclude that equipoise regarding choice of therapy for treatment of cerebral edema in diabetic ketoacidosis should be maintained until a more definitive study is performed to guide therapy of this potentially lethal complication.

1 December 2020 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JBJori Bogetz
Jori Bogetz
ARAnna Revette
Anna Revette
ARAbby R. Rosenberg
Abby R. Rosenberg
DDDanielle D. DeCourcey
Danielle D. DeCourcey

1 April 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
JBJay G. Berry
Jay G. Berry
DGDenise M Goodman
Denise M Goodman
RCRyan J. Coller
Ryan J. Coller
RARishi Agrawal
Rishi Agrawal
DKDennis Z. Kuo
Dennis Z. Kuo
MHMatt Hall
Matt Hall

1 April 2017 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
DDDanielle D. DeCourcey
Danielle D. DeCourcey
MSMelanie Silverman
Melanie Silverman
ECEsther Pharm D Chang
Esther Pharm D Chang
AOAl Ozonoff
Al Ozonoff
CSCarolyn Stickney
Carolyn Stickney
JFJonathan A. Finkelstein
Jonathan A. Finkelstein
Objectives: Although medication reconciliation has become standard during hospital admission, rates of unintentional medication discrepancies during intensive care of pediatric patients with chronic disease are unknown. Such discrepancies are an important cause of adverse drug events in adults with chronic illness and are associated with unintentional discontinuation of chronic medications. We sought to determine the rate, type, timing, and predictors of potentially harmful unintentional medication discrepancies in children and young adults with chronic disease. Design: Prospective observational cohort study. Setting: Patients discharged from the intensive and intermediate care units at a tertiary care children’s hospital from September 2013 to May 2014. Patients: Consecutive sample of 308 patients less than 25 years old with chronic disease defined by prescription of at least one predetermined class of chronic medication prior to hospitalization. Measurements and Main Results: The number of unintentional medication discrepancies with the potential for harm, as well as patient and medication-related factors predisposing patients to these errors were assessed. Two thousand seven hundred thirty-nine medication discrepancies were identified; 284 (10%) were unintentional and had the potential for harm (0.9/patient). Of these, 128 (45%) were due to errors in taking the preadmission medication history, whereas 156 (55%) were due to errors reconciling the medication history with orders. Most events occurred at admission (66%) and were dosing errors (45%). In multivariable negative binomial regression analyses (adjusted rate ratios [95% CI]), each additional preadmission medication (1.07 [1.04–1.10]), chronic respiratory medications (1.51 [1.01–2.28]), and chronic noninvasive ventilation (1.53 [1.07–2.19]) were associated with increased risk of a discrepancy. Conclusions: Unintentional medication discrepancies with the potential for harm are common among children and young adults with chronic disease during critical care admission due to both failure to obtain an accurate medication history and errors in reconciling the history with patient orders. The use of current medication reconciliation processes is insufficient to prevent errors in this high-risk population.